Advertisement
Annovis Bio Says FDA Authorizes Phase 2/3 Trial For Buntanetap In Alzheimer's Disease
(RTTNews) - Annovis Bio, Inc. (ANVS), a late-stage clinical drug platform company, announced Thursday that the U.S. Food and Drug Administration (FDA) has authorized the Phase 2/3 clinical study of buntanetap in moderate Alzheimer's Disease (AD).
Following the submission of the Phase 2a clinical safety data and the chronic toxicology data in animals, the Company requested approval to further pursue the development of buntanetap in AD.
The FDA approved the Company's development plan, study protocol and authorized the initiation of the Phase 2/3 clinical study of buntanetap in AD.
For More Such Health News, visit rttnews.com
read more
Annovis Bio Says Phase III Study Data Release For Buntanetap In Parkinson's Disease Postponed
Drug platform company Annovis Bio, Inc. (ANVS) announced Wednesday a postponement in the Phase III study data release for buntanetap in Parkinson's Disease. This adjustment is due to ongoing data cleaning efforts to ensure the accuracy and reliability of the study results.
RTTNews
|
484 dias atrás
UK Retail Sales Growth Tops Expectations On Warm Weather
UK retail sales rebounded more than expected in April as good weather boosted food store sales, official data showed on Friday. A monthly survey today showed that British consumer confidence strengthened in May on hopes of easing trade tensions and the interest rate reduction by the Bank of England. Retail sales grew 1.2 percent on a monthly basis in April, following a revised 0.1 percent rise
RTTNews
|
27 minutos atrás
European Shares Seen Flat To Higher At Open
European stocks may open flat to slightly higher on Friday as U.S. President Donald Trump's "big, beautiful" tax bill heads to the Senate for debate and review.
RTTNews
|
2 h 54 min atrás
European Economic News Preview: UK Retail Sales Data Due
Retail sales from the UK and detailed quarterly national accounts from Germany are the top economic news due on Friday. At 2.00 am ET, the Office for National Statistics releases UK retail sales for April. Economists forecast retail sales to grow 0.3 percent on a monthly basis, after rising 0.4 percent in March.
RTTNews
|
3 h 40 min atrás
Sensex, Nifty Rebound As US Bond Yields Ease
Indian shares traded higher on Friday as U.S. Treasury yields eased from recent highs on improved economic data and comments from a Federal Reserve official that he still sees a path to interest rate cuts later this year.
RTTNews
|
4 h 16 min atrás
Australian Market Extends Early Gains In Mid-market
The Australian stock market is extending its early gains in mid-market moves on Friday, reversing some of the losses in the previous session, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving to near the 8,400 level, with gains is financial and technology stocks partially offset by weakness in mining and energy stocks.
RTTNews
|
5 h 5 min atrás
Asian Markets Trade Mixed
Asian stock markets are trading mixed on Friday, following the mixed cues from Wall Street overnight, as US Treasury yields eased on improved US data and comments from a US Fed official that he still sees a path to interest rate cuts later this year. Concerns about the fiscal impact of the US Republican tax cut bill is weighing on the markets. Asian markets ended mostly lower on Thursday.
RTTNews
|
5 h 26 min atrás
Sensex, Nifty Seen Higher At Open
Indian shares are seen opening a tad higher on Friday as U.S. Treasury yields eased on improved U.S. data and comments from a Federal Reserve official that he still sees a path to interest rate cuts later this year.
RTTNews
|
5 h 48 min atrás
